. He can be reached at nsaraceno@mjhlifesciences.com.

Videos

In the final part of her Pharma Commerce video interview, Heather Zenk, Cencora’s president of US supply chain, outlines practical, cost-conscious strategies for reducing Scope 3 emissions in pharma supply chains, from smarter warehouse lighting and returnable cold chain packaging, to order consolidation and AI-enabled delivery optimization.

Ways Pharma Supply Chains Can Cut Scope 3 Emissions Now

Articles

With 14 new lawsuits filed and 132 total complaints across 40 states, Novo Nordisk is intensifying efforts to protect patients from unapproved compounded semaglutide products by targeting pharmacies, telehealth providers, and deceptive marketing practices that compromise safety, mislead consumers, and violate FDA regulations.

Novo Nordisk Ramps Up Legal Fight Against Compounded Semaglutide Knockoffs

In the second part of his Pharma Commerce video interview, Philip Sclafani, PwC's pharmaceutical and life sciences lead, discusses how the pharmaceutical industry is balancing high-cost innovation, especially in obesity and metabolic disease, with payer demands for cost containment, highlighting the growing role of biosimilars and future generics in offsetting spend.

How Pharma Can Navigate Innovation and Cost Pressures in the GLP-1 Era

Pharma Pulse 8/6/25: GT-02287 Shows Promise in Parkinson's Patients with and Without GBA1 Mutation; How Remote Monitoring Enhances Trial Efficiency and Patient Safety

In the fifth part of her Pharma Commerce video interview, Heather Zenk, Cencora’s president of US supply chain, explores how public-private collaboration, smarter sourcing strategies, and long-term manufacturer support are helping to fortify pharmaceutical supply chains against future crises.

Lessons From Shortages and Global Disruptions

The online weight loss company launches a $119 starter plan using low-dose semaglutide and behavioral coaching to improve access, reduce side effects, and support sustainable weight loss.

Noom Debuts Microdose GLP-1 Program to Help Reduce Side Effects and Boost Affordability

In the first part of his Pharma Commerce video interview, Philip Sclafani, PwC's pharmaceutical and life sciences lead, shares how he foresees the One Big Beautiful Bill Act reshaping prescription drug spending, and what strategies pharmaceutical companies adopt to mitigate its potential impact on innovation, R&D investment, and M&A activity.

Facing a Crossroads

Pharma Pulse 8/5/25: GAIN Therapeutics Ramps Up for Next Big Step in Parkinson’s Drug Development; Harnessing AI to Advance Clinical Trials and Oncology Pharmacy

In the fourth part of her Pharma Commerce video interview, Heather Zenk, Cencora’s president of US supply chain, explores how public-private collaboration, smarter sourcing strategies, and long-term manufacturer support are helping to fortify pharmaceutical supply chains against future crises.

Pharma Industry Shifts Toward Full Activation

The Spain-based CDMO strengthens its North American presence and capabilities through its purchase, while also acquiring a new rare disease treatment from Sanofi one month prior.

News